XT
KPRX icon

XTX Topco’s Kiora Pharmaceuticals KPRX Stock Holding History

XTX Topco’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,719
Closed -$28.4K – 4450
2026
Q1 		$28.4K Buy
14,719
+2,748
+23% +$5.8K ﹤0.01% 3471
2025
Q4 		$23.6K Buy
+11,971
New +$27.3K ﹤0.01% 3025
2024
Q2 		– Sell
-2,768
Closed -$17.6K – 2179
2024
Q1 		$17.6K Buy
+2,768
New +$15.5K ﹤0.01% 1623
2023
Q4 		– Sell
-1,310
Closed -$6.94K – 1856
2023
Q3 		$6.94K Buy
+1,310
New +$6.71K ﹤0.01% 1448
2021
Q4 		– Sell
-39
Closed -$31K – 847
2021
Q3 		$31K Buy
+39
New +$33.1K 0.01% 630

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

XTX Topco's KPRX Position: Q2 2026 in Review

XTX Topco sold out of Kiora Pharmaceuticals (KPRX) in Q2 2026, closing a stake of 14,719 shares — an estimated $28.4K sold.

XTX Topco first reported a position in KPRX in Q3 2021 and held it in 5 quarters. The position peaked at $31K in Q3 2021. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • XTX Topco reported no remaining Kiora Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 14,719 Kiora Pharmaceuticals shares in Q2 2026, an estimated $28.4K.
  • XTX Topco first reported a position in Kiora Pharmaceuticals in Q3 2021 and held it in 5 quarters.
  • XTX Topco's Kiora Pharmaceuticals position peaked at $31K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.